[NMusers] Pharmacometrics Webinar with Stephan Schmidt, March 14th

From: Rebecca Baillie <rbaillie_at_rosaandco.com>
Date: Thu, 7 Mar 2019 14:39:49 +0000

Pharmacometrics, PBPK, QSP - What's Next?

Stephan Schmidt, B.Pharm, Ph.D., F.C.P.
Center for Pharmacometrics & Systems Pharmacology, University of Florida

 Thursday, March 14, 2019, 12:00 to 1:00 pm EDT

Register at https://www.rosaandco.com/webinars

Abstract: 
Modeling & simulation (M&S) tools have long been used in engineering and ae=
rospace industries to develop products that would be prohibitively expensiv=
e to optimize through iterative improvement of prototypes. Modern drug deve=
lopment is now adapting and integrating analogous tools based on informatio=
n from all phases of the development process since it is neither cost-effec=
tive nor time-efficient to tackle all open questions experimentally. As a r=
esult, an increasing number of decisions are now based on M&S at various le=
vels of physiological and temporal complexity. However, prospective identif=
ication of clinically relevant sources of variability remain a challenge. T=
o overcome this challenge the integrated use of multidisciplinary research =
approaches is needed.

The objective of this webinar is to provide selected case examples that hig=
hlight the added value of integrated use of real-world outcomes-, pharmacom=
etric, and physiologically based pharmacokinetic approaches for identifying=
 clinically-relevant sources of variability and translating them into actio=
nable items.





Received on Thu Mar 07 2019 - 09:39:49 EST

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 17:03:28 EDT